Navigation Links
Evolving Market Access in the APAC Region, a New Xtalks Life Sciences Webinar

Toronto, Canada (PRWEB) March 28, 2013

As the pharmaceutical industry in the West is being challenged with austerity and increasing pricing pressure, companies have started looking to diversify their portfolios through emerging markets. The countries within emerging markets are highly diverse and business models need to be locally tailored to ensure success.

The aim of this webinar is to cover market access related issues in the Asia Pacific region, including Japan and China, representing the world’s second and third largest pharmaceutical markets. South Korea and Taiwan, also major reimbursement markets as well as innovators in biologics and specialty products, will also be discussed.

This session will cover:

Ongoing healthcare reform in China and its implication on access

  • Top level regulatory requirement overview
  • Market access in China: What are Reimbursement Drug List and Essential Drug List and how are prices set?
  • Pricing trends
  • Healthcare reform bill and the impact on distribution channels
  • How to address the affordability issue?

Pricing trends and price premiums in Japan

  • Pricing and access principles
  • Reward for innovation
  • The utility of health economics

HTA in the APAC region:

  • The adaptation of Health Technology Assessment (HTA) in Japan and China
  • The impact of HTA on reimbursement, pricing and access in S Korea and Taiwan

For more information about this event or to register, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit

Zayeeta Dasgupta, M.Sc in Life Science and Business Management
1- (416) 977-6555 ext. 260

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
9. GeneLink Marketing Efforts Poised to Show Results
10. Animal Biotechnology - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Global Stem Cells Group announced ... clinics in the cities of Arica and Iquique in northern Chile. The facilities are part ... offer the most advanced protocols and techniques in stem cell medicine to patients from around ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
(Date:11/30/2015)...  Culprits beware, a University at Albany research ... is taking crime scene fingerprint identification to a ... -->   --> Photo ... --> Halámek and his team ... concept for identifying whether a culprit is male ...
(Date:11/30/2015)... Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or ... Norman C.W. Wong to its Board of Directors to ... Zenith with a wealth of experience as co-founder of Resverlogix, ... --> --> Dr. Wong ... board of directors. Zenith,s long standing expertise in epigenetics and ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
(Date:10/29/2015)... October 29, 2015 NXTD ... company focused on the growing mobile commerce market ... that StackCommerce, a leading marketplace to discover and ... Wocket® smart wallet on StackSocial for this holiday ... or the "Company"), a biometric authentication company focused ...
Breaking Biology News(10 mins):